• 1-(844)-30-STOCK

Need updates On Your Mobile Text STOCKS to 67076

MLSS

MLSS: A Small Float Turnaround With Momentum and Potential Ahead


Date : November 27, 2017

MLSS: A Small Float Turnaround With Momentum and Potential Ahead

New Opportunity:  Milestone Scientific Inc. (NYSE American: MLSS)

We are ready to really hit the gas pedal tomorrow morning as we come down the homestretch for the year. It’s the Holiday Season, and we have a major gift for you today.

MLSS is a small float player (just 18M shares) that recently put in place a potentially bullish triple bottom basing pattern that has our team excited about a deep value turnaround setup in play right now with this interesting stock.

The company has been stacking the wires with huge catalysts, and the stock looks primed for big things ahead.

Symbol:  MLSS

Company:  Milestone Scientific Inc.

Quote:  http://finance.yahoo.com/q?s=MLSS

Latest News:  http://finance.yahoo.com/q/h?s=MLSS+Headlines

Company Website:  http://www.milestonescientific.com

mlss

Who is MLSS

mlss stock

Milestone Scientific Inc. (NYSE American: MLSS) is a leading medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies.

Perhaps the most important asset for the company is its CompuFlo Epidural System, which just received 510(k) clearance from the FDA to take the product to market with no further regulatory hurdles.

Leslie Bernhard was just announced as new CEO, summed it up thus: “Following our recent 510(k) clearance from the U.S. Food and Drug Administration (FDA), we have received extremely positive industry feedback regarding our CompuFlo Epidural System. Both the board and senior management are laser-focused on building a cost-effective global distribution network, which may include strategic partnerships, distribution agreements and/or licensing opportunities. Based on the outcome of these discussions, we will direct resources towards those opportunities that we believe provide the greatest value and return on capital for shareholders. I am fully confident in the ability of the current senior management team to execute on our near-term goals, and longer-term strategic vision to establish CompuFlo as the standard-of-care in painless and precise drug delivery across the U.S., Europe and around the world.”

Milestone Scientific Inc. develops computer-controlled anesthetic delivery instruments for the medical and dental markets in the United States and internationally. The company’s products include STA Single Tooth Anesthesia System Instrument, a computer-controlled local anesthesia delivery instrument that incorporates the pressure feedback elements of its patented CompuFlo technology, which allows dentists to administer injections into the periodontal ligament space; and CompuDent, a computer-controlled local anesthetic delivery instrument that provides painless injections for various routine dental treatments, including implants, root canals, crowns, fillings, and cleanings.

Its products also comprise CompuMed, a computer-controlled injection instrument for use in various applications, such as colorectal surgery, podiatry, dermatology, nasal and sinus surgery, hair transplantation and cosmetic surgery, cosmetic surgery, orthopedics, and others. In addition, the company provides The Wand, a hand piece that allow dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns.

Recent Catalysts

Milestone Scientific Inc. (NYSE American: MLSS) is a leading medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies.

Perhaps the most important asset for the company is its CompuFlo Epidural System, which just received 510(k) clearance from the FDA to take the product to market with no further regulatory hurdles.

The company has been moving forward toward bigger and better things ever since announcing that the CompuFlo Epidural Computer Controlled Anesthesia System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

The CompuFlo Epidural System provides anesthesiologists and other Health Care Providers for the first time, the ability to quantitatively determine and document the pressure at the needle tip in real-time. The CompuFlo Epidural’s proprietary DPS Dynamic Pressure Sensing Technology (DPS) allows the CompuFlo Epidural to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify the epidural space.

The company recent followed that up with a major announcement of plans for the commercial launch of its novel and proprietary cosmetic injection instrument for delivery of botulinum toxin (such as Botox and Dysport). The Global Facial Injectables Market is estimated to witness a CAGR of 10.42% during a forecast period 2017-2023, according to a recent report by Research and Markets. On an average, women have started spending $300-$500 billion a year on related beauty products. This product will help MLSS penetrate into this game.

mlss

The company is also diversifying its income streams. In a recent financial update, Leslie Bernhard, Chairman and Interim Chief Executive Officer of Milestone Scientific stated, “We saw a sharp improvement in domestic dental instrument and handpiece sales, increasing to $1.4 million in the third quarter of 2017 versus $0.1 million for the same period last year, which reflects the transition to our new distributor, Henry Schein, in the third quarter of 2016. Growth in domestic sales was offset by a decline in international sales due to marketing promotions we ran last year, and upfront stocking orders in both Europe and China. We expect to resume international growth in our dental division in 2018 as these distributors sell through inventory. We continue to gain traction through the exclusive product sales team at Henry Schein, which we believe will help further accelerate domestic revenue growth in 2018.”

That’s a HUGE jump in dental related sales.

However, the real meat on the bone of this setup right now is on the chart. The stock has been tracing out a key basing pattern for the better of the past 12 months, with recent action showing a big opportunity coming onto the radar.

Remember, this is a small float play. At just 18M shares in circulation, any kind of a shock of upward momentum or buzz could put this stock squarely into orbit. And we know there’s a bid underneath… hence the triple bottom pattern at key support. That’s an accumulation pattern. It’s a major signal.

Management notes that the appointment follows the resignation of Daniel Goldberger as President and Chief Executive Officer effective October 2, 2017.

Ms. Bernhard is not a final solution. In fact, a formal search has commenced for a new CEO to focus on the medical opportunity. At the same time, the Board of Directors is also evaluating a variety of strategic options in the medical field in light of the Company’s recent 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the CompuFlo Epidural System.

Technical Analysis

This is where you can really see the turnaround taking shape. Take a look at the chart shown here. You may never see a better example of a rock solid triple-bottom pattern in play that the one dominating the chart for MLSS right now.

And keep in mind we are dealing with an 18M share float here. Very small.

The point of this pattern is all about accumulation. There are strong hands willing to absorb supply over the period shown. It’s a floor in the stock. And recently, one can clearly see momentum shifting back to the upside. We would imagine the changes at the company mentioned above have a lot to do with that.

MLSS stock Chart

About MLSS

MLSS (Milestone Scientific Inc.) is a leading medical research and development company that designs and patents innovative injection technologies. Milestone’s computer-controlled systems are designed to make injections precise, efficient, and virtually painless.

Milestone Scientific Inc. develops computer-controlled anesthetic delivery instruments for the medical and dental markets in the United States and internationally. The company’s products include STA Single Tooth Anesthesia System Instrument, a computer-controlled local anesthesia delivery instrument that incorporates the pressure feedback elements of its patented CompuFlo technology, which allows dentists to administer injections into the periodontal ligament space; and CompuDent, a computer-controlled local anesthetic delivery instrument that provides painless injections for various routine dental treatments, including implants, root canals, crowns, fillings, and cleanings.

Its products also comprise CompuMed, a computer-controlled injection instrument for use in various applications, such as colorectal surgery, podiatry, dermatology, nasal and sinus surgery, hair transplantation and cosmetic surgery, cosmetic surgery, orthopedics, and others. In addition, the company provides The Wand, a hand piece that allow dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns.

Milestone Scientific Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.

mlss stock

What You Need To Know:

    •  

      • MLSS has a tiny float of just 18M shares, which could exacerbate any upside momentum we see from current levels and flats and shorts scramble for shares.
      • MLSS recently made some changes at the top that could spark growth ahead and a greater commitment to execution.
      • MLSS also recently got 510(k) clearance from the FDA to market its flagship CompuFlo device technology.
      • MLSS is making real money, with trailing revs already coming in at $10.9M.
      • MLSS is starting to see genuine sales growth, with quarterly y/y revs increasing at 6%. That is before the key product hits the marketplace with fresh marketing as a tailwind.
      • MLSS just recorded a MACD Bullish reversal, suggesting a technical change in trend.
      • MLSS has put in place a very clear and striking triple-bottom pattern that is starting to tip back up to the upside.

Conclusion:

MLSS provides an opportunity where three main points come together: a strong fundamental inflection towards a fresh injection of sales growth, a reshaping of the corporate culture to embrace more of a growth-oriented focus, and a technical picture that demonstrates both a supportive floor and upward momentum with a small float in place.

That is a hard recipe to beat, and certainly deserves a close look.

mlss

Disclaimer :

We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. MyBestStockPicks engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. Neither the owner of Our Newsletter nor any of its members, officers, directors, contractors or employees are licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. If we own any shares we will list the information relevant to the stock and number of shares here.  Mybeststockpicks owns no shares of any of the companies mentioned here within, nor intends to buy any in the future. Mybeststockpicks  has been compensated total of two thousand dollars by ALG Financial  to perform 1 week  investors awareness advertisement on MLSS starting 11/27/2017 Read More

Total Views: 4389 ,